RESUMEN

Because hepatitis A infection may be more severe in patients with chronic liver disease, we vaccinated 33 children who were chronic HBsAg carriers against hepatitis A virus. Anti-hepatitis A virus seroconversion rates after the first, second, and third doses were 90.9%, 96.9%, and 100%, respectively.

Asunto(s)

Hepatitis A/prevención & control , Antígenos de Superficie de la Hepatitis B/análisis , Virus de la Hepatitis B/inmunología , Hepatitis B Crónica/inmunología , Vacunas contra Hepatitis Viral/administración & dosificación , Adolescente , Portador Sano , Niño , Preescolar , Femenino , Hepatitis A/inmunología , Vacunas contra la Hepatitis A , Humanos , Masculino , Vacunación , Vacunas contra Hepatitis Viral/inmunología